• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET XL 360 STANDARD 14MM X 50CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET XL 360 STANDARD 14MM X 50CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0036101450
Medical Device Problem Code Premature Activation (1484)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/15/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Subject device is not available.
 
Event or Problem Description
It was reported that during coil embolization of a lienal artery aneurysm, friction was experienced as the coil (subject device) was advanced inside the microcatheter.The coil eventually became jammed at about 4cm form the proximal part of the microcatheter.While continuing to advance the coil further, the delivery wire was bent and the coil was detached at the detachment zone inside the microcatheter.The coil and microcatheter were removed from the patient¿s body as one unit.No impact to the patient was reported.
 
Additional Manufacturer Narrative
The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.Based on information from the complaint, the coil was re-positioned several times.Flush was intermittent.As per the target coil dfu: " in order to achieve optimal performance of the target detachable coil system and to reduce the risk of thromboembolic complications, it is critical that a continuous infusion of appropriate flush solution be maintained between the femoral sheath and guiding catheter.The 2-tip microcatheter and guiding catheters.The 2-tip microcatheter and stryker neurovascular guidewire and delivery wire.Continuous flush also reduces the potential for thrombus formation on, and crystallization of infusate around, the detachment zone of the target detachable coil." based on the information available an assignable cause of use error was assigned to this investigation.
 
Event or Problem Description
It was reported that during coil embolization of a lienal artery aneurysm, friction was experienced as the coil (subject device) was advanced inside the microcatheter.The coil eventually became jammed at about 4cm form the proximal part of the microcatheter.While continuing to advance the coil further, the delivery wire was bent and the coil was detached at the detachment zone inside the microcatheter.The coil and microcatheter were removed from the patient¿s body as one unit.No impact to the patient was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET XL 360 STANDARD 14MM X 50CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
MDR Report Key6156027
Report Number3008881809-2016-00298
Device Sequence Number994513
Product Code HCG
UDI-Device Identifier04546540711298
UDI-Public(01)04546540711298(17)190331(10)18922281
Combination Product (Y/N)N
PMA/510(K) Number
K123377
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2019
Device Catalogue NumberM0036101450
Device Lot Number18922281
Was Device Available for Evaluation? No
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 11/15/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date12/08/2016
Supplement Report FDA Received Date03/01/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
RENEGADE MICROCATHETER (STRYKER)
Patient Age56 YR
-
-